Objective: The objective of this article is to study the etiology of community-acquired pneumonia in children with airway malacia. Methods: We retrospectively reviewed the medical records of 428 pneumonia patients. All patients underwent bronchoscopy, and bronchoalveolar lavage samples were processed for microbiological assessment. Results: In a total of 428 cases reviewed, 60 were found to have airway malacia. Pathogens were identified in 44 of the 60 specimens (73.3%), with 32 being single-pathogen infections. The most common pathogen was respiratory syncytial virus (RSV; 20%). Mixed-pathogen infections were observed in 12 patients. Airway malacia patients were younger than those without malacia (10.5 vs. 50 months, respectively; p < 0.001). Compared with those without airway malacia, wheezing, cyanosis and admission to the pediatric intensive care unit were more common in children with airway malacia and their hospital stay was longer. Conclusion: RSV was the most common pathogen in those with airway malacia. Airway malacia was found to aggravate infectious pneumonia.
I N T R O D U C T I O N
Protracted or recurrent pneumonia poses a significant challenge to the pediatricians. Children with airway malacia often have protracted courses of airway infections because dynamic airway collapse during coughing results in impaired mucociliary clearance and retention of tracheobronchial secretions [1] [2] [3] . Zhang et al. found that underlying diseases, such as airway abnormalities, are associated with severe acute lower respiratory infections [4] . Furthermore, Gokdemir et al. [5] found that malacia disorders were the most common causes (7.0%) of persistent and recurrent pneumonia.
Previous studies have focused on the association among recurrent wheeze, chronic cough and airway malacia, with few reports focusing on the etiologic organisms responsible for recurrent or persistent pneumonia with airway malacia. In a study by Boogaard et al. [5] , recurrent lower respiratory tract infections were found in 60 of 96 (63%) patients with airway malacia, and in 77.9% of the children with malacia, at least one pathogen was cultured.
A more recent investigation by De Baets et al. [6] reported that 56% of the children reviewed with persistent respiratory symptoms had a positive bronchoalveolar lavage culture. These findings suggest protracted bacterial infection as a possible cause of persistent respiratory symptoms.
Little is known about the pathogens and clinical features in protracted and recurrent pneumonia patients with airway malacia. The aim of this study was to determine the pathogens and clinical manifestations of protracted and recurrent pneumonia in children with airway malacia, and to compare these with pneumonia in children with no airway malacia to provide a basis for a reasonable choice of antibiotic.
M A T E R I A L S A N D M E T H O D S

Patients
This study was retrospectively conducted on patients with protracted or recurrent pneumonia who were admitted to the Department of Respiratory Disease at the Children's Hospital Soochow University, China, from January 2014 to December 2015. Protracted pneumonia is defined as a lower respiratory tract infection persisting for !30 days; recurrent pneumonia is defined as at least two pneumonia episodes within 1 year [5] . Patients with congenital heart disease, immune deficiency, neuromuscular disease or foreign body aspiration were excluded from the study.
Bronchoscopy BAL fluid (BALF) samples were taken from all patients and assessed for respiratory pathogens. 'Laryngomalacia' is the inward collapse of the supraglottic structures of the glottis on inspiration, causing airway obstruction. 'Tracheomalacia' is a tracheal deformity at the end of expiration, maintained during spontaneous respiration but that can be altered by the passage of the bronchoscope or positive airway pressure. 'Bronchomalacia' is the appearance of a deformity in the right or left mainstem bronchi and/or their respective divisions at the lobar or segmental level. Tracheomalacia and/or bronchomalacia can be classified as mild (less than one-third invagination), moderate (one-third to one-half invagination) or severe (more than four-fifth invagination) [7] . For BALF collection, the bronchoscope was inserted into the bronchus and three samples in 1.0 ml/kg normal saline solution were taken. Indications for bronchoscopy include unexplained hemoptysis or chronic excitant cough, pulmonary atelectasis, local stridor, tracheal and bronchial pulmonary hypoplasia and deformity, pulmonary diffuse disease and protracted or recurrent pulmonary infections. Contraindications for bronchoscopy include severe arrhythmia, cardiac failure, severe respiratory failure, severe bleeding tendency and coagulation dysfunction [8] .
Detection of pathogens Direct immunofluorescence was used to detect syncytial viral infection (respiratory syncytial virus, RSV), influenza virus A, influenza virus B, parainfluenza virus (PIV) I, PIV II, PIV III and adenovirus (ADV). All assay kits were purchased from Chemicon International, Inc. (Billerica, MA, USA), and all staining procedures were done according to the manufacturer's instructions. Immunostained preparations were viewed using a Leica 020-518.500 fluorescence microscope (Leica Microsystems, Wetzlar, Germany). 
Detection of the human metapneumovirus gene
Detection of bacteria
We prepared cultures for quantitative analysis to assess the presence of common aerobic and anaerobic bacteria. Selected media (e.g. Columbia AGAR blood plate, chocolate tablet) were inoculated and placed in a carbon dioxide incubator (50 ml/l) (YAMATO, Ltd, Tokyo, Japan) at 35.0 C for 18$24 h. Bacteria were identified based on the characteristics of their colonies, Gram staining, microscopic performance and biochemical reaction.
C-reactive protein detection
Blood samples were taken from each patient and were measured using the XE-2000i Automated Hematology System (SYSMEX, Kobe, Japan); C-reactive protein (CRP) was detected by immune scattering turbidimetry using the HITACHI 7600-010 automatic biochemical analyzer (Hitachi, Ltd., Tokyo, Japan).
Serology testing for Mycoplasma pneumoniae and
Chlamydophila pneumonia The presence of specific IgM and IgG antibodies against Mycoplasma pneumoniae (MP) was investigated in serum samples of patients using a commercial ELISA kit (Serion ELISA classic M. pneumoniae IgG/IgM, Institute Virion/Serion, Germany). IgA and IgG antibodies against Chlamydophila pneumoniae were detected with Serion ELISA classic C. pneumoniae IgA/IgG kits.
Statistical analyses
All data were analyzed using PASW 20.0. Comparisons among groups were performed using the Chi-squared test. Fisher's exact probability test was used to analyze data that did not meet the requirements for the Chi-squared test. Data that were not normally distributed were compared using the Mann-Whitney U test. Here, p < 0.05 was considered statistically significant.
R E S U L T S
Patient characteristics
The records of 428 patients were examined for the study. In all, 60 suffered from airway malacia (Table  1) ; the remaining 368 patients were used as the control group. There were 43 (71.6%) males and 17 (28.3%) females. Seventeen patients (28.3%) were-<6.0 months old, 16 (26.7%) were from 6 months to 1.0 year old, 18 (30%) were from 1.0 to 3.0 years old, 5 (8.3%) were from 3.0 to 5.0 years old and 4 (6.7%) were >5.0 years old. The control group (n ¼ 368) was composed of 199 (54.1%) males and 169 (45.9%) females. Patients whose parents refused bronchoscopy and those patients with bronchoscopy contraindications were excluded from the study. The number of patients whose parents refused bronchoscopy was 45. Two patients were with bronchoscopy contraindications. The diagnoses in this group were recurrent/protracted pneumonia (n ¼ 22), bronchial asthma (n ¼ 9), Bordetella pertussis-like symptoms (n ¼ 9), gastroesophageal reflux (n ¼ 2), atelectasis (n ¼ 2), pleural effusion (n ¼ 1), respiratory failure (n ¼ 1) and heart failure (n ¼ 1).
Pathogens
Pathogens were identified in 44 of 60 (73.3%) specimens from patients with airway malacia, of which 32 were single-pathogen infections. RSV was the most common single pathogen affecting 12 cases (37.5%). The most common mixed-pathogen infection was MP þ RSV (25.0%) in 12 patients (Table 2) .
Pathogens were identified in 249 of 368 specimens with no airway malacia (67.7%) of which 188 Comparison of clinical features of CAP patients with and without airway malacia Airway malacia patients were younger than those without malacia (10.5 vs. 50 months, p < .001). The proportion of males with airway malacia was higher than that of females (73.7% vs. 26.7%, p ¼ 0.005). Wheezing, cyanosis and admission to pediatric intensive care unit (PICU) were more common in children with airway malacia (68.3% vs. 30.9%, p < 0.001; 8.3% vs. 0.8%, p ¼ 0.002; 11.7% vs. 3.5%, p ¼ 0.013). The average hospital stay was longer in children with airway malacia (10 days vs. 8.0 days, p ¼ 0.004). MP (81.4%) was the most common single pathogen in CAP patients without airway malacia while virus (56.3%) was the most common pathogen with airway malacia (Table 4) . Comparison of clinical features of single-and mixed-pathogen infection in CAP patients without airway malacia Of those CAP patients without airway malacia, the proportion of males with mixed-pathogen infections was higher than that of females. CRP was higher in those with mixed-pathogen infections without airway malacia than in those with single-pathogen infections (Table 5) .
Comparison of clinical features of single-and mixed-pathogen infections in CAP with airway malacia There was no significant difference in clinical characteristics, such as age, fever, wheezing, dyspnea, cyanosis, admission to PICU and hospital stay, between patients with single-pathogen infections and those with mixed-pathogen infections in CAP with airway malacia (Table 6 ).
Associations between severity of airway malacia and PICU stay and duration of hospitalization No statistically significant associations between severity of airway malacia and PICU admission and duration of hospitalization were observed in the airway malacia group (Table 7) .
D I S C U S S I O N
Current management of lower respiratory tract infections in children with airway malacia, which includes liberal use of antibiotics and physiotherapy, is not evidence based [9] ; therefore, determining the correct pathogen is particularly important for determining the correct treatment. This is the first study examining the etiology of pneumonia with airway malacia in China. Of the 60 protracted and recurrent CAP cases with airway malacia, with a positive pathogen detection rate of 73.3%, we found RSV to be the most common pathogen, followed by SP and Table 5 . Demographic and clinical features of single-pathogen and mixed-pathogen infections in community-acquired pneumonia without airway malacia MP. However, in CAP patients without airway malacia, MP was the most common pathogen, the results of which are different from those of previous reports of 10-40% [10, 11] . In addition, RSV and MP incidences were higher than those in previous reports [12, 13] . De Baets et al. [6] studied 124 children with persistent respiratory symptoms and fiberoptic bronchoscopy with BAL were performed; they found that 47% of cases had structural abnormality of the central airways, 56% of BAL samples tested positive for bacterial culture with Moraxella catarrhalis (51%), HI (28%), SP (13%), Staphylococcus aureus (10%). The pathogen detection rate was higher than that in our study, and the pathogen was different.
In those patients with tracheobronchomalacia, which lack specific clinical symptoms, Pan et al. [14] studied 459 cases of children with airway malacia and found chronic cough and wheezing to be the main clinical manifestations, accompanied by difficulty in breathing, fever and sputum production. In the present study, we found that wheezing and cyanosis were common in patients with airway malacia. Patients with airway malacia had higher rates of admission to PICU and longer hospital stays, suggesting that airway malacia aggravated the disease. However, no significant associations between severity of airway malacia and PICU admission and duration of hospitalization were observed. Our study was consistent with Masters et al. [15] , who reported that children with malacia have an increased disease severity and a tendency for delayed recovery. Whether mixed-pathogen infection increases the severity of pneumonia remains controversial. Some studies showed that viruses and bacteria in a mixedpathogen infection prolongs hospitalization and increases the risk of admission to PICU [16] [17] [18] [19] . However, other studies have shown no significant difference between average hospital stay, hospitalization rates and mortality when comparing mixedpathogen infections with single-pathogen infections in patients with pneumonia [20] [21] [22] . In our study, we found the CRP level was higher in the mixedpathogen infection group. The rate of admission to PICU and the length of hospital stay showed no obvious differences between the two groups, indicating that mixed-pathogen infections have no relationship to protracted and recurrent CAP patient mortality.
C O N C L U S I O N S
This study found that airway malacia is the underlying cause predisposing to persistence or recurrence of pneumonia in children; co-existing airway malacia did aggravate the disease. RSV was the most common pathogen, and mixed-pathogen infection accounted for 20% of infections. Thus, when treating children with protract and recurrent pneumonia who do not respond to antibiotics treatment, clinicians should consider airway malacia as a possible precipitant and perform a bronchoscopy.
S T U D Y L I M I T A T I O N S
This study had some limitations. First, it was a retrospective study. Second, it was a single-center study. Third, there was no study of potential fungal pathogens. Finally, there was a certain selection bias because patients who refused bronchoscopy were not included in the study. 
A C K N O W L E D G E M E N T S
